This article examines how conflicting notions of the body politic between the pure and the non secular have contextualised the evolution of cardiology. After a quick take a look at the place of the coronary heart in biblical, patristic and medieval notions of the church, the article turns to the Reformation interval. While Martin Luther moved theological gravity to the particular person’s coronary heart and conscience, his up to date Michael Servetus described the pulmonary cycle in the context of an antitrinitarian theology condemned as theological and political heresy.
In the early trendy interval, nature conceived as creation grounded sovereign political authority, which science may then align with. Whereas William Harvey nonetheless adhered to an Aristotelian teleology, René Descartes and subsequent mechanistic contributions to cardiology had been flanked by an intense ‘cardiolatry’. Both, it’s argued, are two sides of the similar, nearly non-corporeal coin. The rising Enlightened epistemology allowed for a place distinct from each sovereign and ecclesial powers. The French Revolution was a paradigm shift: the ancien régime falls, and its Sacred Heart devotion is mocked; the new ‘Erastian’ state-university emerges as the context of cardiology.
These developments are mirrored in the lifetime of René Laënnec and in cultural interpretations of the coronary heart later in the 19th century. It is proven that the coronary heart as a doubly inscribed, each organic and non secular organ, performed a central function in theological, and subsequently political and scientific notions of the body politic. These proceed to hang-out the current, permitting us to interpret normative appeals to the coronary heart notably in political contexts. KSA is the largest sovereign nation in the Middle East and the largest free market economic system in the Middle East and North Africa.
A nationwide psychological well being coverage has been in existence since 2006, however psychological well being spending nonetheless is lower than in most different high-income international locations. The Ministry of Health has not too long ago begun creating a brand new healthcare system primarily based on a patient-centered mannequin of care that may combine care of psychological problems with care of bodily problems. Previous epidemiological analysis on psychological problems in KSA has been restricted, making the SNMHS vital for coverage planning functions to acquire correct estimates of prevalence, remedy, and obstacles to remedy.
Engineering Education in Cold War Diplomacy: India, Germany, and the Establishment of IIT Madras*
The Indian Institute of Technology Madras (IIT) was arrange with help of the Federal Republic of Germany between 1956 and 1974. It grew to become the largest, and lastly, a profitable techno-scientific schooling challenge undertaken by the Federal Republic outdoors of Germany. In this paper, I argue that the engagement of the Federal Republic at IIT Madras must be understood primarily as a challenge of Cold-War science and expertise diplomacy, which on the German aspect was geared toward stopping an Indian recognition of the German Democratic Republic as a sovereign nation.
In aiding the institution of IIT Madras, the Federal Republic got here into direct competitors with the Soviet Union, which supported IIT Bombay but additionally with the United States of America, which supported IIT Kanpur. The help to determine IIT Madras and its governance adopted primarily political tips, to which academic and scientific features had been rendered subordinate. When the challenge was in a disaster after the first State Treaty to determine IIT Madras expired in 1963, the political flagship challenge of the Federal Republic was not allowed to fail. Instead, the cooperation was reorganized and assist elevated.
Narratives of Injustice: An Investigation of Toxic Dumping inside the Blackfeet Nation
For over 50 years, the individuals of the Amskapi Piikani (Blackfeet) Nation have relayed info of “one thing dangerous” being covertly dumped inside their remaining homelands. These tales, addressing contaminated waste and the areas of rumored dump websites, have additionally been linked with perceived most cancers clusters amongst residents who dwell inside the Blackfeet Nation. The idea of environmental injustice suggests that usually the most susceptible populations, together with communities of coloration, expertise the most adverse realities of environmental poisonous exposures, and it’s not unusual for poisonous wastes to be disposed of inside Native American lands.
Given that Blackfeet communities endure from a few of the highest charges of most cancers in the state of Montana, these narratives warrant additional investigation. This analysis examined whether or not illicit dumping inside Blackfeet sovereign lands will be substantiated and if this can be a case of environmental injustice. This investigation employed a mixture of each conventional Indigenous and Western-based scientific methodologies, each quantitative and qualitative.
Alpha-bungarotoxin, CF680r |
|||
9-00003 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF640r |
|||
9-00004 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin, CF640r |
|||
9-00004 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF488a |
|||
9-00005 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin CF488a |
|||
9-00005 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF568 |
|||
9-00006 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin, CF568 |
|||
9-00006 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF594 |
|||
9-00007 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin CF594 |
|||
9-00007 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF633 |
|||
9-00009 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin, CF633 |
|||
9-00009 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin |
|||
00010-1 | Biotium | 1MG | EUR 168 |
Description: Minimum order quantity: 1 unit of 1MG |
Fluorescein-Alpha-bungarotoxin |
|||
00011 | Biotium | 500uG | EUR 367 |
Description: Minimum order quantity: 1 unit of 500uG |
Tetramethylrhodamine-Alpha-bungarotoxin |
|||
00012 | Biotium | 500uG | EUR 383 |
Description: Minimum order quantity: 1 unit of 500uG |
Fluorescein-alpha-bungarotoxin: (10x50ug) |
|||
00013 | Biotium | 10ST | EUR 417 |
Description: Minimum order quantity: 1 unit of 10ST |
Tetramethylrhodamine-alpha-bungarotoxin: (10x50ug) |
|||
00014 | Biotium | 10ST | EUR 466 |
Description: Minimum order quantity: 1 unit of 10ST |
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (500ug) |
|||
00015 | Biotium | 500uG | EUR 466 |
Description: Minimum order quantity: 1 unit of 500uG |
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (10x50ug) |
|||
00016 | Biotium | 10ST | EUR 523 |
Description: Minimum order quantity: 1 unit of 10ST |
Biotin-xx-a-bungarotoxin |
|||
00017 | Biotium | 500uG | EUR 433 |
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-Bungarotoxin, CF555 conjugate |
|||
9-00018 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-Bungarotoxin, CF555 conjugate |
|||
9-00018 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100ug |
Biotin-cAMP, diisopropylethylammonium salt: |
|||
00020 | Biotium | 1MG | EUR 314 |
Description: Minimum order quantity: 1 unit of 1MG |
Biotin-cAMP, diisopropylethylammonium salt: (20x50ug) |
|||
00020-1 | Biotium | 20ST | EUR 418 |
Description: Minimum order quantity: 1 unit of 20ST |
Biotin-cGMP, diisopropylethylammonium salt: |
|||
00021 | Biotium | 1MG | EUR 344 |
Description: Minimum order quantity: 1 unit of 1MG |
Biotin-cGMP, diisopropylethylammonium salt: (20x50ug) |
|||
00021-1 | Biotium | 20ST | EUR 448 |
Description: Minimum order quantity: 1 unit of 20ST |
Cyanine 644-cAMP: |
|||
00022 | Biotium | 1MG | EUR 491 |
Description: Minimum order quantity: 1 unit of 1MG |
Cyanine 644-cAMP: (20x50ug) |
|||
00022-1 | Biotium | 20ST | EUR 625 |
Description: Minimum order quantity: 1 unit of 20ST |
Fluorescein Methotrexate, triammonium salt: |
|||
00023 | Biotium | 1MG | EUR 281 |
Description: Minimum order quantity: 1 unit of 1MG |
Staurosporine |
|||
00025 | Biotium | 100uG | EUR 139 |
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF543 |
|||
00026 | Biotium | 500uG | EUR 494 |
Description: Minimum order quantity: 1 unit of 500uG |
Rhodamine phalloidin 300u |
|||
00027 | Biotium | 300 | EUR 345 |
Description: Minimum order quantity: 1 unit of 300 |
Biotin-xx-phalloidin |
|||
00028 | Biotium | 100U | EUR 428 |
Description: Minimum order quantity: 1 unit of 100U |
Fluorescein-phalloidin |
|||
00030 | Biotium | 300U | EUR 345 |
Description: Minimum order quantity: 1 unit of 300U |
Rhodamine 110 phalloidin |
|||
00032 | Biotium | 300ST | EUR 345 |
Description: Minimum order quantity: 1 unit of 300ST |
Sulforhodamine 101 (Texas-Red) Phalloidin |
|||
00033 | Biotium | 300EU | EUR 345 |
Description: Minimum order quantity: 1 unit of 300EU |
Phalloidin, CF405M |
|||
00034 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF405M |
|||
00034-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
CF488A-cAMP |
|||
00036 | Biotium | 100ug | EUR 172 |
Description: Minimum order quantity: 1 unit of 100ug |
CF640R-cAMP |
|||
00037 | Biotium | 100ug | EUR 172 |
Description: Minimum order quantity: 1 unit of 100ug |
Phalloidin, CF555 |
|||
00040 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF555 |
|||
00040-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF647 |
|||
00041 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF647 |
|||
00041-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF488A |
|||
00042 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF488A |
|||
00042-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF543 |
|||
00043 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF543 |
|||
00043-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF568 |
|||
00044 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF568 |
|||
00044-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF594 |
|||
00045 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF594 |
|||
00045-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF633 |
|||
00046 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF633 |
|||
00046-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF660R |
|||
00047 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF660R |
|||
00047-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF680R |
|||
00048 | Biotium | 300U | EUR 466 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF680R |
|||
00048-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF350 |
|||
00049 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF350 |
|||
00049-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF640R |
|||
00050 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF640R |
|||
00050-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF532 |
|||
00051 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF532 |
|||
00051-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF660C |
|||
00052 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF660C |
|||
00052-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF680 |
|||
00053 | Biotium | 300U | EUR 466 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF680 |
|||
00053-T | Biotium | 50U | EUR 147 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF430 |
|||
00054 | Biotium | 300U | EUR 449 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF430 |
|||
00054-T | Biotium | 50U | EUR 139 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF440 |
|||
00055 | Biotium | 300U | EUR 449 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF440 |
|||
00055-T | Biotium | 50U | EUR 139 |
Description: Minimum order quantity: 1 unit of 50U |
Cholera Toxin Subunit B, CF488A conjugate |
|||
00070 | Biotium | 100ug | EUR 261 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF568 conjugate |
|||
00071 | Biotium | 100ug | EUR 261 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF594 conjugate |
|||
00072 | Biotium | 100ug | EUR 261 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF640R conjugate |
|||
00073 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF532 conjugate |
|||
00074 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF543 conjugate |
|||
00075 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF620R conjugate |
|||
00076 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF633 conjugate |
|||
00077 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF660R conjugate |
|||
00078 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF680R conjugate |
|||
00079 | Biotium | 100ug | EUR 282 |
Description: Minimum order quantity: 1 unit of 100ug |
Human Transferrin, CF488A conjugate |
|||
00081 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF543 conjugate |
|||
00082 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF568 conjugate |
|||
00083 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF594 conjugate |
|||
00084 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF640R conjugate |
|||
00085 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF680R conjugate |
|||
00086 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF750 conjugate |
|||
00087 | Biotium | 1mg | EUR 155 |
Description: Minimum order quantity: 1 unit of 1mg |
HIV-1 tat recombinant antigen |
|||
00110-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 tat recombinant antigen full length 15 kDa |
HIV-1 tat recombinant antigen |
|||
00110-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 tat recombinant antigen full length 15 kDa |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 nef recombinant antigen |
|||
00112-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
HIV-1 nef recombinant antigen |
|||
00112-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
HIV-1 env gp41 recombinant antigen |
|||
00113-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa |
HIV-1 env gp41 recombinant antigen |
|||
00113-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa |
HIV-2 GP 36 Recombinant Antigen |
|||
00114-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
HIV-2 GP 36 Recombinant Antigen |
|||
00114-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
HCV core recombinant antigen |
|||
00115-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
HCV core recombinant antigen |
|||
00115-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
HCV core recombinant antigen, Biotin conjugate |
|||
00115-V-B-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
HCV core recombinant antigen, Biotin conjugate |
|||
00115-V-B-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
HCV core recombinant antigen, FITC conjugate |
|||
00115-V-F-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. |
HCV core recombinant antigen, FITC conjugate |
|||
00115-V-F-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. |
HCV core recombinant antigen, Rhodamine |
|||
00115-V-R-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. |
HCV core recombinant antigen, Rhodamine |
|||
00115-V-R-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. |
HCV NS4 recombinant antigen NS4a+b |
|||
00116-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. |
HCV NS4 recombinant antigen NS4a+b |
|||
00116-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. |
HCV NS4 recombinant antigen NS4a+b, Biotin |
|||
00116-V-B-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. |
HCV NS4 recombinant antigen NS4a+b, Biotin |
|||
00116-V-B-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. |
HCV NS4 recombinant antigen NS4a+b, FITC |
|||
00116-V-F-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. |
HCV NS4 recombinant antigen NS4a+b, FITC |
|||
00116-V-F-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. |
HCV NS4 recombinant antigen NS4a+b, Rhodamine |
|||
00116-V-R-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. |
HCV NS4 recombinant antigen NS4a+b, Rhodamine |
|||
00116-V-R-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. |
HCV NS3 recombinant antigen |
|||
00117-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa |
HCV NS3 recombinant antigen |
|||
00117-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa |
HBV core recombinant antigen |
|||
00120-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa |
HBV core recombinant antigen |
|||
00120-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa |
HBV core recombinant antigen, Delta |
|||
00121-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa |
HBV core recombinant antigen, Delta |
|||
00121-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa |
HBV surface recombinant antigen HBsAg |
|||
00122-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant |
HBV surface recombinant antigen HBsAg |
|||
00122-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant |
HBV surface recombinant antigen HBsAg antigen |
|||
00123-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
HBV surface recombinant antigen HBsAg antigen |
|||
00123-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
HBV surface recombinant antigen HBsAg antigen |
|||
00124-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
HBV surface recombinant antigen HBsAg antigen |
|||
00124-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
HEV (Birma) ORF2 recombinant antigen |
|||
00131-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. |
HEV (Birma) ORF2 recombinant antigen |
|||
00131-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. |
HEV (Birma) ORF2 recombinant antigen |
|||
00132-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. |
HEV (Birma) ORF2 recombinant antigen |
|||
00132-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. |
AA 403-461 HEV Birma ORF2 Recombinant Antigen |
|||
00133-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. |
AA 403-461 HEV Birma ORF2 Recombinant Antigen |
|||
00133-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. |
T, Pallidum recombinant antigen p15 |
|||
00141-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: T. Pallidum recombinant antigen p15 (full length) |
T, Pallidum recombinant antigen p15 |
|||
00141-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: T. Pallidum recombinant antigen p15 (full length) |
T, Pallidum recombinant antigen p17 |
|||
00142-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: T. Pallidum recombinant antigen p17 (full length) |
T, Pallidum recombinant antigen p17 |
|||
00142-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: T. Pallidum recombinant antigen p17 (full length) |
T, Pallidum recombinant antigen p45 |
|||
00143-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: T. Pallidum recombinant antigen p45 (full length) |
T, Pallidum recombinant antigen p45 |
|||
00143-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: T. Pallidum recombinant antigen p45 (full length) |
T, pallidum recombinant antigen TmpA |
|||
00144-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: T. Pallidum recombinant antigen TmpA (full length) |
T, pallidum recombinant antigen TmpA |
|||
00144-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: T. Pallidum recombinant antigen TmpA (full length) |
HCV core 2-119aa recombinant antigen |
|||
00150-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a |
HCV core 2-119aa recombinant antigen |
|||
00150-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a |
HCV Core 24 Antigen |
|||
00151-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core 24 antigen. |
HCV Core 24 Antigen |
|||
00151-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core 24 antigen. |
HCV core recombinant antigen |
|||
00152-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a.105-302 |
HCV core recombinant antigen |
|||
00152-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a.105-302 |
HCV NS3 1192-1456 aa Recombinant Antigen |
|||
00153-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS3 1192-1456aa recombinant antigen a.a.1192-1459. Available genotypes: 1a, 1b, 2b, 2c, 5, 6a |
HCV NS3 1192-1456 aa Recombinant Antigen |
|||
00153-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS3 1192-1456aa recombinant antigen a.a.1192-1459. Available genotypes: 1a, 1b, 2b, 2c, 5, 6a |
HCV NS3 1359-1456aa antigen |
|||
00154-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6 |
HCV NS3 1359-1456aa antigen |
|||
00154-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6 |
HCV NS4 mosaic recombinant antigen |
|||
00155-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. |
HCV NS4 mosaic recombinant antigen |
|||
00155-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. |
HCV NS4 1916-1947aa recombinant antigen |
|||
00156-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 1916-1947aa recombinant antigen. |
Traditional methodologies included the use of Indigenous oral narratives. These oral narratives are then additional knowledgeable with Western processes of doc overview and geologic, water, and radiation surveys. The authors discovered compelling proof by the oral histories and doc evaluations for poisonous dumping inside Blackfeet lands; nevertheless, cursory water and radiation surveys weren’t conclusive.
This preliminary inquiry supplies the basis for additional analysis wanted to press this investigation. Three focus teams had been carried out, wherein 26 individuals had been proven a prototype of a consumer interface for a self-sovereign blockchain-based PHR system (ie, a system wherein the particular person owns, has custody of, and controls entry to their private well being info) for use for privateness and safe well being information sharing. A microinterlocutor evaluation of focus group transcriptions was carried out to indicate a descriptive overview of participant responses. NVivo 12.zero was used to code the classes of the responses.